SEI INVESTMENTS CO - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$389,830
+74.3%
6,483
+112.6%
0.00%
Q4 2022$223,627
-7.2%
3,049
-4.1%
0.00%
-100.0%
Q3 2022$241,000
+5.2%
3,178
-8.6%
0.00%
Q2 2022$229,000
-25.2%
3,476
-6.4%
0.00%
-100.0%
Q1 2022$306,000
+12.1%
3,714
+2.3%
0.00%0.0%
Q4 2021$273,000
-22.0%
3,630
+20.1%
0.00%0.0%
Q3 2021$350,000
-48.8%
3,023
-2.0%
0.00%
-50.0%
Q2 2021$684,000
-47.3%
3,085
-68.6%
0.00%
-33.3%
Q1 2021$1,298,000
-44.4%
9,817
-27.3%
0.00%
-50.0%
Q4 2020$2,336,000
+3.2%
13,502
-33.2%
0.01%
-14.3%
Q3 2020$2,263,000
-15.0%
20,213
-55.0%
0.01%
-12.5%
Q2 2020$2,663,000
+15.7%
44,916
+31.4%
0.01%0.0%
Q1 2020$2,302,000
-3.0%
34,182
+21.4%
0.01%
+14.3%
Q4 2019$2,373,000
-8.9%
28,154
-17.3%
0.01%0.0%
Q3 2019$2,606,000
-2.9%
34,037
-21.7%
0.01%
-22.2%
Q2 2019$2,683,000
+15.2%
43,453
-10.2%
0.01%
+12.5%
Q1 2019$2,330,000
-26.2%
48,367
-19.7%
0.01%
-27.3%
Q4 2018$3,158,0000.0%60,2610.0%0.01%0.0%
Q3 2018$3,158,000
+36.5%
60,261
-18.5%
0.01%
+37.5%
Q2 2018$2,314,000
+461.7%
73,923
+290.7%
0.01%
+300.0%
Q1 2018$412,000
+7.9%
18,923
+0.0%
0.00%
+100.0%
Q4 2017$382,000
-3.8%
18,915
-5.5%
0.00%0.0%
Q3 2017$397,00020,0100.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders